92 related articles for article (PubMed ID: 29714648)
1. Metastatic breast cancers: Estimates for Italy.
Crocetti E; Gori S; Falcini F
Tumori; 2018; 104(2):116-120. PubMed ID: 29714648
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
Wang K; Shi Y; Li ZY; Xiao YL; Li J; Zhang X; Li HY
Eur J Surg Oncol; 2019 Aug; 45(8):1364-1372. PubMed ID: 30837102
[TBL] [Abstract][Full Text] [Related]
4. Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.
Wilson S; Speers C; Tyldesley S; Chia S; Kennecke H; Ellard S; Lohrisch C
Clin Breast Cancer; 2016 Aug; 16(4):284-90. PubMed ID: 26705158
[TBL] [Abstract][Full Text] [Related]
5. Estimating prevalence of distant metastatic breast cancer: a means of filling a data gap.
Clements MS; Roder DM; Yu XQ; Egger S; O'Connell DL
Cancer Causes Control; 2012 Oct; 23(10):1625-34. PubMed ID: 22850901
[TBL] [Abstract][Full Text] [Related]
6. Time trends in population-based breast cancer survival in Estonia: analysis by age and stage.
Baburin A; Aareleid T; Padrik P; Valvere V; Innos K
Acta Oncol; 2014 Feb; 53(2):226-34. PubMed ID: 23767956
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic factors associated with de novo metastatic breast cancer.
Shen T; Siegal GP; Wei S
Pathol Res Pract; 2016 Dec; 212(12):1167-1173. PubMed ID: 27692496
[TBL] [Abstract][Full Text] [Related]
9. Left laterality is an independent prognostic factor for metastasis in N3 stage breast cancer.
Karatas F; Sahin S; Erdem GU; Ates O; Babacan T; Akin S; Sever AR; Ozisik Y; Altundag K
J BUON; 2016; 21(4):851-858. PubMed ID: 27685905
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer under age 40: a different approach.
Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F
Curr Treat Options Oncol; 2015 Apr; 16(4):16. PubMed ID: 25796377
[TBL] [Abstract][Full Text] [Related]
12. Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.
Dal Maso L; Toffolutti F; De Paoli A; Giudici F; Francisci S; Bucchi L; Zorzi M; Fusco M; Caldarella A; Rossi S; De Angelis R; Botta L; Ravaioli A; Casella C; Musolino A; Vitale MF; Mangone L; Fanetti AC; Carpin E; Burgio Lo Monaco MG; Migliore E; Gambino ML; Ferrante M; Stracci F; Gasparotti C; Carrozzi G; Cavallo R; Mazzucco W; Ballotari P; Ferretti S; Sampietro G; Rizzello RV; Boschetti L; Cascone G; Mian M; Pesce MT; Piras D; Galasso R; Bella F; Seghini P; Pinna P; Crocetti E; Serraino D; Guzzinati S;
Int J Cancer; 2024 Jul; 155(2):270-281. PubMed ID: 38520231
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
15. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
[TBL] [Abstract][Full Text] [Related]
16. Survival of de novo stage IV breast cancer patients over three decades.
Hölzel D; Eckel R; Bauerfeind I; Baier B; Beck T; Braun M; Ettl J; Hamann U; Harbeck N; Kiechle M; Mahner S; Schindlbeck C; de Waal J; Engel J
J Cancer Res Clin Oncol; 2017 Mar; 143(3):509-519. PubMed ID: 27853869
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
[TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures--report 2006: 1. Incidence, mortality and estimates.
AIRT Working Group
Epidemiol Prev; 2006; 30(1 Suppl 2):8-10, 12-28, 30-101 passim. PubMed ID: 16826725
[TBL] [Abstract][Full Text] [Related]
19. Survival in familial and non-familial breast cancer by age and stage at diagnosis.
Kharazmi E; Försti A; Sundquist K; Hemminki K
Eur J Cancer; 2016 Jan; 52():10-8. PubMed ID: 26630529
[TBL] [Abstract][Full Text] [Related]
20. Recurrence dynamics does not depend on the recurrence site.
Demicheli R; Biganzoli E; Boracchi P; Greco M; Retsky MW
Breast Cancer Res; 2008; 10(5):R83. PubMed ID: 18844974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
